Rh-Endostatin (Endostar®) Continuous Intravenous Infusion
Clinical trial NCT03706703 · UNKNOWN
Trial details
- NCT number
- NCT03706703
- Sponsor
- Affiliated Cancer Hospital & Institute of Guangzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2020-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.